Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data.
about
Extrahepatic manifestations of chronic hepatitis C virus infectionPathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogenAssociation of Hepatitis C Virus Infection with Type II Diabetes in Ethiopia: A Hospital-Based Case-Control StudyTreatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs.Production and pathogenicity of hepatitis C virus core gene products.Dental problems delaying the initiation of interferon therapy for HCV-infected patients.Hepatitis C virus itself is a causal risk factor for chronic kidney disease beyond traditional risk factors: a 6-year nationwide cohort study across TaiwanAssociation of Periodontal Diseases and Liver Fibrosis in Patients With HCV and/or HBV infection.Relationship between hepatitis C virus infection and type 2 diabetes mellitus: meta-analysis.Effect of soy protein supplementation in patients with chronic hepatitis C: a randomized clinical trial.Very-low-density lipoprotein (VLDL)-producing and hepatitis C virus-replicating HepG2 cells secrete no more lipoviroparticles than VLDL-deficient Huh7.5 cells.Application of network construction to estimate functional changes to insulin receptor substrates 1 and 2 in Huh7 cells following infection with the hepatitis C virusMaternal HCV infection is associated with intrauterine fetal growth disturbance: A meta-analysis of observational studiesClinical features of patients with type 2 diabetes mellitus and hepatitis C infection.New insights into HCV-related rheumatologic disorders: A review.Role of lipid metabolism in hepatitis C virus assembly and entry.What is expected from the pathologist in the diagnosis of viral hepatitis?Safety and efficacy of metformin in patients with type 2 diabetes mellitus and chronic hepatitis C.Chronic hepatitis C in the aged: much ado about nothing or nothing to do?Hepatitis C virus and autoimmunity.Reversible autonomic dysfunction during antiviral treatment in patients with chronic hepatitis C virus infection: Anti-HCV therapy and autonomic function.Chronic hepatitis C virus infection is associated with increased risk of preterm birth: a meta-analysis of observational studies.Matched population-based study examining the risk of type 2 diabetes in people with and without diagnosed hepatitis C virus infection.Oxidative stress is closely associated with insulin resistance in genotypes 1 and 3 chronic hepatitis C.Role of IL28B genotyping in patients with hepatitis C virus-associated mixed cryoglobulinemia and response to PEG-IFN and ribavirin treatment.Association between IL28B polymorphism, TNFα and biomarkers of insulin resistance in chronic hepatitis C-related insulin resistance.Insulin resistance in non-diabetic patients of chronic Hepatitis C.High plasma level of nucleocapsid-free envelope glycoprotein-positive lipoproteins in hepatitis C patients.Perspectives on the management of chronic hepatitis B and C.Hypoglycemia in a diabetic patient during hepatitis C therapy.Hepatitis C Infection and Periodontal Disease: Is there a Common Immunological Link?
P2860
Q26767084-7BB0406E-02A0-44FB-AA0D-C055E899B65AQ26861095-D83A6BA6-44EF-49D9-8297-F050A5ADC4D9Q30422090-F90B8C01-002E-4E90-B721-C90367E22E09Q30751889-FB101F24-221F-4CCD-B019-0C3FD101A983Q33780095-55F99AE7-28AC-4149-B4DF-22CB60410206Q34104997-55C9CA7F-140A-44B0-8598-91D0E8610AD8Q34980383-777B178B-0AEE-4C26-9FE5-74217C631A69Q35085706-28C7E264-6E33-41BB-A229-E53B89FF266FQ35886690-98730BEC-7E9D-44CE-8071-9A3A17FE2407Q35958241-702BCD3B-A687-4781-AA72-284C48071102Q36760026-2804F2AB-7F70-475B-9276-075659F5FFA3Q37190820-61EA9D46-FD4B-452D-BF7C-0B0870FAB3B0Q37226463-920085F4-BADE-4502-9045-631B322D665BQ37370876-C63BCB9E-D0FF-46DF-BB2E-58AB854622BCQ37610871-B4B9EE41-A5E7-4483-BE07-C2B7CC10DFF4Q37621569-42BE438C-6EAF-4F36-A5DD-C55BD42C9A04Q37848125-05D16932-0599-4E02-B6F3-641EF6AF3E7FQ38164686-9A67D4B3-B6C5-4B3D-A9F6-B813A4C806F5Q38198992-B4D64CFF-0A28-4355-880A-1700A295FC8DQ38497354-E97D140A-4570-4437-A2E9-3482DD46AD64Q38914740-175AF90A-9555-4C9A-BF4E-3CAAC6C9D5F6Q38994989-29319EE9-F7C4-4974-B673-B4AB32933995Q39972632-9C486273-C350-41EF-97E4-CA020DF1FB4DQ40707274-BADC6C61-7299-4F06-9FEA-52AAA633BCD4Q41172281-731B23E0-5AA8-4123-BB40-F278D8694103Q41375331-914A53C0-2F99-48B8-BFAC-E986AB7120BEQ42024080-182221F3-0359-4828-A68B-B1A3D990C23DQ42977206-8423CD7A-9BA0-4F1B-B74D-67F835E79AA1Q42986676-0B9FCD0E-2B80-48F6-9292-2884CA7DD36BQ54778333-3A2FA2E4-39C1-48C0-9B3D-54EFE1CBA97EQ55133381-288C8C78-3787-4E36-B16E-207FCE47DF86
P2860
Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data.
@ast
Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data.
@en
type
label
Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data.
@ast
Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data.
@en
prefLabel
Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data.
@ast
Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data.
@en
P1433
P1476
Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data.
@en
P2093
Jacqueline Capeau
Lawrence Serfaty
P356
10.1111/J.1478-3231.2008.01952.X
P478
29 Suppl 2
P577
2009-03-01T00:00:00Z